Close Menu

NEW YORK (360Dx) – Swedish diagnostic developer Immunovia today announced it has received a SEK4.9 million ($585,000) follow-on grant to support development studies for its Immray PanCan-d blood-based test for the early detection of pancreatic cancer.

The grant is from the Swelife Accelerator Innovation Program, which is designed to support Sweden's small-to-medium-sized enterprises. The Create Health Translational Cancer Center at Lund University will collaborate with Immunovia on its studies.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.